Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Tower Resources (TWR) reports first assay results from Rabbit North Property in British Columbia
  • The results come from its new Thunder Zone where hole 39 returned 2.04 g/t gold over 25.7 metres
  • This grade at the Thunder Zone is higher than the 1.5 g/t average grade of the Lightning Zone
  • The company said the Thunder Zone also appears to have much greater continuity, both along strike and to depth
  • Shares of Tower Resources (TWR) are down 11.34 per cent to C$0.43 as of 10:54 a.m. EDT

Tower Resources (TWR) reports first assay results from its Rabbit North Property in British Columbia.

The results come from its new Thunder Zone, where hole 39 returned 2.04 g/t gold over 25.7 metres.

In a press release, the company said the hole intersected two gold zones, a 3.0 metre upper zone from 142.7 metre down-hole grading 4.02 g/t gold.

The targeted Thunder zone started at 17.8 metres further downhole, at 163.5 metres grading 2.04 g/t gold over 25.7 metres.

Tower Resources said the 2.04 g/t grade at the Thunder Zone is much higher than the 1.5 g/t average grade of the Lightning Zone.

“The Thunder Zone is building as expected, with the indicated gold grade double that of most open pit gold mines in B.C. And its relatively undisturbed condition and previously indicated continuity both along strike and to depth make the Thunder Zone more predictable and drill-friendly than the Lightning Zone. Together these features should allow us to build a significant gold resource more quickly,” Stu Averill, a director of the company, said in a release.

The company also drilled hole 40, which is 50 metres northeast of hole 39. Hole 40 intersected a 7.65 metre mineralized zone containing 1.42 g/t gold.

Assays are currently pending for hole 41.

Shares of Tower Resources (TWR) are down 11.34 per cent to C$0.43 as of 10:54 a.m. EDT.

More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.